Adaptive Biotechnologies
Price & Volume
Stats
See more52W Range | $4.27-$15.57 |
Market Cap | $2.3B |
Shares Short | 9M |
Financials
See moreRevenue (12 Mos) | $205.2M |
Revenue Growth (YoY) | 36.3% |
Gross Profit (12 Mos) | $125.7M |
Diluted EPS | -$0.81 |
News
See moreYahoo Finance • last month
Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
Yahoo Finance • 2 months ago
Adaptive Biotechnologies (NASDAQ:ADPT) Fits Minervini's Trend Template with Strong Growth Momentum
Yahoo Finance • 2 months ago
Piper Sandler raises Adeptus Biotechnologies stock price target on growth outlook
Yahoo Finance • 2 months ago
Adaptive Biotechnologies soars 8.5% as MRD business achieves profitability
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 619 |
